Meet the innovators working out of The Cannon Houston's brand new space

Houston innovators podcast episode 5

This week's episode of the Houston Innovators Podcast highlights 11 different entrepreneurs at a live recording at The Cannon Houston's grand opening event. Courtesy of Quy Tran/The Cannon

Last week, The Cannon Houston premiered its new digs in West Houston with a grand opening event attended by an incredible group of innovators, entrepreneurs, friends, family, and even puppies.

InnovationMap and the Houston Innovators Podcast had a presence at the festivities as well, which has allowed us to put together a special edition of the podcast. Rather than recording an interview with one entrepreneur in studio, this week's episode features 11 interviews with over a dozen innovators.

Here's who all you'll hear from — in order — in this episode:

  • Werner Winterboer of SapMok, a South African sustainable shoe making company that's looking to expand in Houston.
  • Brad Greer of DrySee, a liquid bandage company that's created a wetness indicator that allows for a patient to know if their bandage has been compromised thus preventing infection risks.
  • Chris Bayardo of Bayardo Safety LLC, a small compliance company that uses tech to optimize the oil and gas industry's compliance issues.
  • Dirk Van Slyke of Statistical Vision, a marketing consultancy that taps into data and metrics to help organizations take their company to the next level.
  • Aaron Knape of sEATz, an app that has perfected the mobile food and drink ordering process in stadiums.
  • Matt and Adam Woods of Skippermyboat, a tourism startup that helps travelers easily connect with boating adventures all over the world.
  • Mike T. Brown of Win-Win, a sports tech company that gamifies the donation process for causes supported by professional athletes.
  • Alex Taghi, Aimee Robert, and Jeffery Abel of Co-Counsel, the coworking concept for lawyers and attorneys.
  • Jeff Miller of Potentia, an education and staffing platform that helps place autistic employees with their right employer.
  • Drew Wadley with MiTyket, which has created a software that can prevent price gouging in the live entertainment industry.
  • Bret Bloch with Four Tower LLC, which provides integrated solutions for projects and operations.

Check out the episode below and subscribe wherever you get your podcasts.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.